Literature DB >> 10356056

Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases.

F Provini1, G Plazzi, P Tinuper, S Vandi, E Lugaresi, P Montagna.   

Abstract

Nocturnal frontal lobe epilepsy (NFLE) has been delineated as a distinct syndrome in the heterogeneous group of paroxysmal sleep-related disturbances. The variable duration and intensity of the seizures distinguish three non-rapid eye movement-related subtypes: paroxysmal arousals, characterized by brief and sudden recurrent motor paroxysmal behaviour; nocturnal paroxysmal dystonia, motor attacks with complex dystonic-dyskinetic features; and episodic nocturnal wanderings, stereotyped, agitated somnambulism. We review the clinical and polysomnographic data related to 100 consecutive cases of NFLE in order to define the clinical and neurophysiological characteristics of the different seizure types that constitute NFLE. NFLE seizures predominate in males (7:3). Age at onset of the nocturnal seizures varies, but centres during infancy and adolescence. A familial recurrence of the epileptic attacks is found in 25% of the cases, while 39% of the patients present a family history of nocturnal paroxysmal episodes that fit the diagnostic criteria for parasomnias. A minority of cases (13%) have personal antecedents (such as birth anoxia, febrile convulsions) or brain CT or MRI abnormalities (14%). In many patients, ictal (44%) and interictal (51%) EEGs are uninformative. Marked autonomic activation is a common finding during the seizures. NFLE does not show a tendency to spontaneous remission. Carbamazepine completely abolishes the seizures in approximately 20% of the cases and gives remarkable relief (reduction of the seizures by at least 50%) in another 48%. VideoEEG recordings confirm that NFLE comprises a spectrum of distinct phenomena, different in intensity but representing a continuum of the same epileptic condition. We believe that the detailed clinical and videoEEG characterization of patients with NFLE represents the first step towards a better understanding of the pathogenic mechanisms and different clinical outcomes of the various seizure types that constitute the syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10356056     DOI: 10.1093/brain/122.6.1017

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  73 in total

Review 1.  Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.

Authors:  Romina Combi; Leda Dalprà; Maria Luisa Tenchini; Luigi Ferini-Strambi
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

2.  Management of epilepsy.

Authors:  T Deonna
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

3.  Nocturnal frontal lobe epilepsy: there is bad, good, and very good news!

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

Review 4.  [The neurology of REM sleep. A synoptic tour de force].

Authors:  N J Diederich
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

5.  To sleep, perchance to seize: surgery ameliorates nocturnal frontal lobe seizures.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2008 Jan-Feb       Impact factor: 7.500

Review 6.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 7.  Neuroendocrine aspects of improving sleep in epilepsy.

Authors:  Doodipala Samba Reddy; Shu-Hui Chuang; Dayton Hunn; Amy Z Crepeau; Rama Maganti
Journal:  Epilepsy Res       Date:  2018-08-31       Impact factor: 3.045

8.  Nicotine normalizes intracellular subunit stoichiometry of nicotinic receptors carrying mutations linked to autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Cagdas D Son; Fraser J Moss; Bruce N Cohen; Henry A Lester
Journal:  Mol Pharmacol       Date:  2009-02-23       Impact factor: 4.436

9.  Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.

Authors:  M I Read; J C Harrison; D S Kerr; I A Sammut
Journal:  Br J Pharmacol       Date:  2015-08-24       Impact factor: 8.739

10.  Not Only Sleepwalking But NREM Parasomnia Irrespective of the Type Is Associated with HLA DQB1*05:01.

Authors:  Anna Heidbreder; Birgit Frauscher; Thomas Mitterling; Matthias Boentert; Anja Schirmacher; Paul Hörtnagl; Harald Schennach; Christina Massoth; Svenja Happe; Geert Mayer; Peter Young; Birgit Högl
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.